Identifying risk factors for treatment selection in NLST
Principal Investigator
About this CDAS Project
Study
NLST
(Learn more about this study)
Project ID
NLST-15
Initial CDAS Request Approval
Apr 9, 2013
Title
Identifying risk factors for treatment selection in NLST
Summary
The goal of this project is use NLST data to extend methodology for combining risk factors to improve the identification of a possible promising subgroup with a higher benefit than on average. The method combines three previous methods: the adaptive signature design, benefit prediction via a difference in estimated risks between randomization groups, and the sliding window subpopulation treatment effect pattern plot. Special approaches are considered for survival data.
References:
Baker SG, Kramer BS, Sargent DJ, Bonetti M. Biomarkers, subgroup evaluation, and trial design. Discovery Medicine 2012, 13(70):187-192.
Baker SG. and Kramer BS. Towards precision medicine: a simple method for identifying and evaluating biomarkers for treatment selection using randomized trials. Under submission
References:
Baker SG, Kramer BS, Sargent DJ, Bonetti M. Biomarkers, subgroup evaluation, and trial design. Discovery Medicine 2012, 13(70):187-192.
Baker SG. and Kramer BS. Towards precision medicine: a simple method for identifying and evaluating biomarkers for treatment selection using randomized trials. Under submission
Aims
To adapt my software and modify my methodology for use with NLST data. Some challenges include large numbers of controls and missing data.
Collaborators
Ping Hu
Barry Kramer